Showing results (321-330 of 379) with videos related to
Sort By:
Pageof 38
American Journal of Respiratory and Critical Care Medicine|December 22, 2021
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del AllelesSimon Y Graeber, Constanze Vitzthum, Sophia T Pallenberg, et al.American Journal of Respiratory and Critical Care Medicine|March 15, 2023
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del AlleleJennifer L Goralski, Jordana E Hoppe, Marcus A Mall, et al.Nature Medicine|September 7, 2010
CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammationVeronica Marcos, Zhe Zhou, Ali Onder Yildirim, et al.Proceedings of the National Academy of Sciences of the United States of America|April 30, 2024
CCR3-dependent eosinophil recruitment is regulated by sialyltransferase ST3Gal-IVRoland Immler, Katrin Nussbaumer, Axel Doerner, et al.ERJ Open Research|March 12, 2024
Multiple-breath washout to detect lung disease in patients with inborn errors of immunityLeonie M Busack, Stephanie Thee, Yvonne Liu, et al.BMJ Open|April 17, 2023
RECAST: Study protocol for an observational study for the understanding of the increased REsilience of Children compared to Adults in SARS-CoV-2 infecTionSebastian Stricker, Niklas Ziegahn, Martin Karsten, et al.American Journal of Respiratory and Critical Care Medicine|June 2, 2025
Long-Term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Children ≥6 Years with Cystic Fibrosis and at Least One F508del Allele: A 192-Week, Phase 3, Open-Label Extension StudyClaire Wainwright, Susanna A McColley, Paul McNally, et al.IEEE Transactions on Medical Imaging|August 4, 2025
In vivo 4D x-ray dark-field lung imaging in miceYing Ying How, Nicole Reyne, Michelle K Croughan, et al.Frontiers in Medicine|November 28, 2024
Automated lung segmentation on chest MRI in children with cystic fibrosisFriedemann G Ringwald, Lena Wucherpfennig, Niclas Hagen, et al.The European Respiratory Journal|January 19, 2019
Targeting of cathepsin S reduces cystic fibrosis-like lung diseaseDonna M Small, Ryan R Brown, Declan F Doherty, et al.Pageof 38